Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
The report details the trend, potential and market size of Pneumonia Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pneumonia Treatment Drugsmarket, defines the market attractiveness level of Pneumonia Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pneumonia Treatment Drugs industry, describes the types of Pneumonia Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pneumonia Treatment Drugs market and the development prospects and opportunities of Pneumonia Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pneumonia Treatment Drugs market in Chapter 13.
By Player:
Mylan
Combioxin
Shinogi
Arsanis
Pfizer
AstraZeneca
Theravance Biopharma
Sun Pharmaceutical
GlaxoSmithKline
Novartis
Teva Pharmaceutical
Medicines
MSD
By Type:
Macrolides
Cephalosporin
Penicillin
Tetracyclines
Fluoroquinolones
Vancomycin
Other Antibiotics
Immunotherapy Drug
Vaccines
Interferon
By End-User:
Hospital
Clinic
Drugstore
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pneumonia Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pneumonia Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pneumonia Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pneumonia Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pneumonia Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.2 United States Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.4 China Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.6 India Pneumonia Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Pneumonia Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Pneumonia Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Pneumonia Treatment Drugs Consumption Forecast (2022-2028)
9 Global Pneumonia Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Pneumonia Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Macrolides Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cephalosporin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Penicillin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Tetracyclines Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Vancomycin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Immunotherapy Drug Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Interferon Consumption and Growth Rate (2017-2022)
-
9.2 Global Pneumonia Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Drugstore Consumption and Growth Rate (2017-2022)
10 Global Pneumonia Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Pneumonia Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Macrolides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Penicillin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Vancomycin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Other Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Immunotherapy Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pneumonia Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
11 Global Pneumonia Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pneumonia Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pneumonia Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pneumonia Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pneumonia Treatment Drugs Market Competitive Analysis
-
14.1 Mylan
-
14.1.1 Mylan Company Details
-
14.1.2 Mylan Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Mylan Pneumonia Treatment Drugs Product and Service
-
14.2 Combioxin
-
14.2.1 Combioxin Company Details
-
14.2.2 Combioxin Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Combioxin Pneumonia Treatment Drugs Product and Service
-
14.3 Shinogi
-
14.3.1 Shinogi Company Details
-
14.3.2 Shinogi Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Shinogi Pneumonia Treatment Drugs Product and Service
-
14.4 Arsanis
-
14.4.1 Arsanis Company Details
-
14.4.2 Arsanis Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Arsanis Pneumonia Treatment Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Pneumonia Treatment Drugs Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Pneumonia Treatment Drugs Product and Service
-
14.7 Theravance Biopharma
-
14.7.1 Theravance Biopharma Company Details
-
14.7.2 Theravance Biopharma Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Theravance Biopharma Pneumonia Treatment Drugs Product and Service
-
14.8 Sun Pharmaceutical
-
14.8.1 Sun Pharmaceutical Company Details
-
14.8.2 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sun Pharmaceutical Pneumonia Treatment Drugs Product and Service
-
14.9 GlaxoSmithKline
-
14.9.1 GlaxoSmithKline Company Details
-
14.9.2 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Pneumonia Treatment Drugs Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Pneumonia Treatment Drugs Product and Service
-
14.11 Teva Pharmaceutical
-
14.11.1 Teva Pharmaceutical Company Details
-
14.11.2 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Teva Pharmaceutical Pneumonia Treatment Drugs Product and Service
-
14.12 Medicines
-
14.12.1 Medicines Company Details
-
14.12.2 Medicines Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Medicines Pneumonia Treatment Drugs Product and Service
-
14.13 MSD
-
14.13.1 MSD Company Details
-
14.13.2 MSD Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 MSD Pneumonia Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pneumonia Treatment Drugs
-
Figure Pneumonia Treatment Drugs Picture
-
Table Global Pneumonia Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumonia Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pneumonia Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pneumonia Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pneumonia Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumonia Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pneumonia Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Macrolides Consumption and Growth Rate (2017-2022)
-
Figure Global Cephalosporin Consumption and Growth Rate (2017-2022)
-
Figure Global Penicillin Consumption and Growth Rate (2017-2022)
-
Figure Global Tetracyclines Consumption and Growth Rate (2017-2022)
-
Figure Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
Figure Global Vancomycin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Drugstore Consumption and Growth Rate (2017-2022)
-
Figure Global Macrolides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Penicillin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vancomycin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferon Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugstore Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pneumonia Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pneumonia Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Pneumonia Treatment Drugs Product and Service
-
Table Combioxin (Foundation Year, Company Profile and etc.)
-
Table Combioxin Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Combioxin Pneumonia Treatment Drugs Product and Service
-
Table Shinogi (Foundation Year, Company Profile and etc.)
-
Table Shinogi Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shinogi Pneumonia Treatment Drugs Product and Service
-
Table Arsanis (Foundation Year, Company Profile and etc.)
-
Table Arsanis Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arsanis Pneumonia Treatment Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pneumonia Treatment Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Pneumonia Treatment Drugs Product and Service
-
Table Theravance Biopharma (Foundation Year, Company Profile and etc.)
-
Table Theravance Biopharma Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Theravance Biopharma Pneumonia Treatment Drugs Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Pneumonia Treatment Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Pneumonia Treatment Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pneumonia Treatment Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Pneumonia Treatment Drugs Product and Service
-
Table Medicines (Foundation Year, Company Profile and etc.)
-
Table Medicines Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medicines Pneumonia Treatment Drugs Product and Service
-
Table MSD (Foundation Year, Company Profile and etc.)
-
Table MSD Pneumonia Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table MSD Pneumonia Treatment Drugs Product and Service
-
